Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Opus Genetics shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $8 price target.

benzinga_article

Jun 17, 2026 at 05:04 PM

Opus Genetics shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $8 price target.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

Sep 10, 2026 at 08:54 AMAAPL: Memory Costs Surge, Price Hikes Loom — Can Foldables Save the Day?
Sep 10, 2026 at 08:58 AMOracle Q1 Preview: Stock Down 53% From Record High, Analyst Says Buy and Hold — 'A Decade Stock'

Opus Genetics

IRD.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--

LongbridgeAI